References
- DoroshowJHChabnerBALongoDLAnthracyclines and anthracenedionesCancer Chemotherapy and Biotherapy3rd edPhiladelphia, PALippincott Williams and Wilkins2001
- HerrIGasslerNFriessHBuchlerMWRegulation of differential pro- and anti-apoptotic signaling by glucocorticoidsApoptosis20071227129117191112
- NuutinenURopponenASuorantaSDexamethasone-induced apoptosis and up-regulation of Bim is dependent on glycogen synthase kinase-3Leuk Res2009331714171719559478
- SuiLLMooreMJTannockIFHillRPBristowRGHarringtonLPharmacology of anticancer drugsThe Basic Science of Oncology4th edNew York, NYMcGraw-Hill2005
- TokimotoCPzadurRCancer management: A multidisciplinary approach: Medical, surgical, and radiation oncologyPrinciples of Chemotherapy8th edNew York, NYPPR2004
- DuguetEVasseurSMornetSDevoisselleJMMagnetic nanoparticles and their applications in medicineNanomedicine (Lond)2006115716817716105
- DaveSRGaoXHMonodisperse magnetic nanoparticles for biodetection, imaging, and drug delivery: A versatile and evolving technologyWiley Interdiscip Rev Nanomed Nanobiotechnol2009158360920049819
- SchroederUSommerfeldPUlrichSSabelBANanoparticle technology for delivery of drugs across the blood-brain barrierJ Pharm Sci199887130513079811481
- LinBLShenXDCuiSApplication of nanosized Fe3O4 in anticancer drug carriers with target-orientation and sustained-release propertiesBiomed Mater2007213213418458446
- JarpeMBWidmannCKnallCAnti-apoptotic versus pro-apoptotic signal transduction: Checkpoints and stop signs along the road to deathOncogene199817147514829779994
- KarinMGretenFRNF-kappa B: Linking inflammation and immunity to cancer development and progressionNat Rev Immunol2005574975916175180
- LevineAJOrenMThe first 30 years of p53: Growing ever more complexNat Rev Cancer2009974975819776744
- ReedJCRegulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistanceCurr Opin Oncol199575415468547403
- SunQChenBAWangXMPreparation of Fe3O4-magnetic nanoparticles loaded with adriamycin and its reversal of multidrug resistance in vitroZhongguo Shi Yan Xue Ye Xue Za Zhi20071574875117708796
- YanFJiangYLiYMZhenXCenJFangWRReversal of P-glycoprotein and multidrug resistance-associated protein 1 mediated multidrug resistance in cancer cells by HZ08 isomers, tetrataisohydro-quinolin derivativesBiol Pharm Bull20083112631264
- ZhaoYPChenGFengBMicroarray analysis of gene expression profile of multidrug resistance in pancreatic cancerChin Med J (Engl)20071201743175218028764
- DevitaVTDose response in alive and wellJ Clin Oncol19864115711593525764
- SomaCEDubernetCBentolilaDBenitaSCouvreurPReversion of multidrug resistance by co-encapsulation of doxorubicin and cyclosporine A in polyalkylcyanoacrylate nanoparticlesBiomaterials2000211710619673
- ZhangRYWangXMWuCHSynergistic enhancement effect of magnetic nanoparticles on anticancer drug accumulation in cancer cellsNanotechnology2006173622362619661614
- ChenBAChengJShenMFMagnetic nanoparticle of Fe3O4 and 5-bromotetrandrin interact synergistically to induce apoptosis by daunorubicin in leukemia cellsInt J Nanomedicine20094657119421371
- WangJQChenBAChengJXuWLSunXCComparison of reversal effects of 5-bromotetrandrine and tetrandrine on P-glycoprotein-dependent resistance to adriamycin in human leukemia cell line K562/A02Ai Zheng20082749149518479598
- KerrJFWinterfordCMHarmonBVApoptosis: Its significance in cancer and cancer therapyCancer199473201320268156506
- KojimaKKonoplevaMSamudioIJMDM2 antagonists induce p53-dependent apoptosis in AML: Implications for leukemia therapyBlood20051063150315916014563
- GhoshSMayMJKoppEBNF-kappa B and Rel proteins: Evolutionarily conserved mediators of immune responsesAnnu Rev Immunol1998162252609597130
- TurcoMCRomanoMFPetrellaABisogniRTassonePVenutaSNF-kappa B/Rel-mediated regulation of apoptosis in hematologic malignancies and normal hematopoietic progenitorsLeukemia200418111714574329
- OttonelloLBertolottoMMontecuccoFBianchiGDallegriFDelayed apoptosis of human monocytes exposed to immune complexes is reversed by oxaprozin: Role of the Akt/IkappaB kinase/nuclear factor kappaB pathwayBr J Pharmacol200915729430619338579